Transcription of 07.315 Rotavirus Vaccine Biological Page
{{id}} {{{paragraph}}}
Example: dental hygienist
07.315 Rotavirus Vaccine Biological Page
Alberta Health Services Standard # August 10, 2022 Immunization Program Standards Manual Page 1 of 5 Provincial Population and Public Health Rotavirus Vaccine Biological Page Section 7: Biological Product Information Standard #: Created by: Province-wide Immunization Program, Standards and Quality Approved by: Province-wide Immunization Program, Standards and Quality Approval Date: June 1, 2015 Revised: August 10, 2022 Rotarix RotaTeq Manufacturer GlaxoSmithKline Inc. Merck Canada Inc. Biological Classification Live, attenuated Live, attenuated Indications for Provincially Funded Vaccine Healthy infants starting immunization at 2 months up to and including 19 weeks (19 weeks 6 days) of age. Vaccine will routinely be offered at the 2 and 4 month immunization appointments. Healthy, non-hospitalized preterm infants can receive this Vaccine based on their chronological age.
However, expert opinion supports administration of rotavirus vaccine at any time before, concurrent with or after administration of immune globulins or other blood products. • Postpone vaccine administration for infants suffering from moderate or severe diarrhea or vomiting.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: